share_log

普利制药:关于全资子公司安徽普利药业有限公司钆特酸葡胺原料药收到FDA接收通知函的公告

Pulley Pharmaceutical: Announcement on the receipt of a notification letter from the FDA for its wholly-owned subsidiary Anhui Puli Pharmaceutical Co., Ltd.

Jun 20, 2022 04:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more